Raymond James & Associates Zymeworks Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$4.65 - $7.43 $19,929 - $31,844	4,286 Added 2.65%	165,933 $1.02 Million
Q2 2022 Aug 12, 2022	SELL	$4.82 - $7.7 $37,779 - $60,352	-7,838 Reduced 4.62%	161,647 $857,000
Q1 2022 May 11, 2022	SELL	$6.0 - $16.98 $353,634 - $1 Million	-58,939 Reduced 25.8%	169,485 $1.11 Million
Q4 2021 Feb 08, 2022	SELL	$15.19 - $29.33 $993,395 - $1.92 Million	-65,398 Reduced 22.26%	228,424 $3.74 Million
Q3 2021 Nov 02, 2021	BUY	$27.35 - $37.28 $906,871 - $1.24 Million	33,158 Added 12.72%	293,822 $8.53 Million
Q2 2021 Aug 11, 2021	SELL	$26.5 - $38.23 $432,294 - $623,645	-16,313 Reduced 5.89%	260,664 $9.04 Million
Q1 2021 May 14, 2021	BUY	$29.83 - $56.81 $3.01 Million - $5.74 Million	101,052 Added 57.44%	276,977 $8.75 Million
Q4 2020 Feb 12, 2021	SELL	$39.12 - $54.99 $10,405 - $14,627	-266 Reduced 0.15%	175,925 $8.31 Million
Q3 2020 Nov 04, 2020	BUY	$29.21 - $46.58 $1.3 Million - $2.07 Million	44,513 Added 33.8%	176,191 $8.22 Million
Q2 2020 Jul 28, 2020	BUY	$33.67 - $40.0 $442,221 - $525,360	13,134 Added 11.08%	131,678 $4.75 Million
Q1 2020 Apr 21, 2020	BUY	$24.28 - $49.8 $643,128 - $1.32 Million	26,488 Added 28.77%	118,544 $4.21 Million
Q4 2019 Feb 12, 2020	SELL	$24.84 - $45.46 $506,413 - $926,793	-20,387 Reduced 18.13%	92,056 $4.19 Million
Q3 2019 Nov 07, 2019	BUY	$22.78 - $29.08 $432,979 - $552,723	19,007 Added 20.34%	112,443 $2.79 Million
Q2 2019 Aug 06, 2019	BUY	$15.0 - $22.49 $565,680 - $848,142	37,712 Added 67.68%	93,436 $2.06 Million
Q1 2019 May 06, 2019	BUY	$14.02 - $16.74 $123,586 - $147,563	8,815 Added 18.79%	55,724 $902,000
Q4 2018 Feb 11, 2019	SELL	$10.95 - $15.44 $42,880 - $60,463	-3,916 Reduced 7.7%	46,909 $689,000
Q3 2018 Nov 14, 2018	BUY	$12.21 - $16.61 $143,467 - $195,167	11,750 Added 30.07%	50,825 $798,000
Q2 2018 Aug 14, 2018	BUY	$11.13 - $21.86 $434,904 - $854,179	39,075 New	39,075 $578,000

Others Institutions Holding ZYME

# of Institutions

Shares Held

296K

Call Options Held

Put Options Held

Strategic Wealth Advisors Group, LLC Sacramento, CA

296K
Shares

$4.34 Million
0.08% of portfolio

View Full List

About Zymeworks Inc.

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $903M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

More about ZYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account